title: Clinical considerations for the treatment of body dysmorphic disorder with cognitive-behavioral therapy.
abstract: Although cognitive behavior therapy has been found to be very effective in the treatment of body dysmorphic disorder (BDD), there still remain a number of challenges that clinicians face in the treatment of individuals with BDD. In this article, we discuss issues related to comorbid depression, suicidality, substance use disorders, personality disorders as well as the role of early life experiences, delusional intensity of beliefs, and motivation to change. The aim of this review is to provide a treatment aid to clinicians by offering specific recommendations for improved care based on the available literature as well as our clinical experience.
authors.affiliation: Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
authors.forename: Ulrike
authors.initials: U
authors.lastname: Buhlmann
authors.forename: Hannah E
authors.initials: HE
authors.lastname: Reese
authors.forename: Stefanie
authors.initials: S
authors.lastname: Renaud
authors.forename: Sabine
authors.initials: S
authors.lastname: Wilhelm
mesh_terms: D001828:Body Image; D015928:Cognitive Behavioral Therapy / Q000379:methods*; D003702:Delusions / Q000453:epidemiology / Q000523:psychology / Q000628:therapy; D003865:Major Depressive Disorder / Q000453:epidemiology / Q000523:psychology / Q000628:therapy; D006801:Humans; D009042:Motivation; D010554:Personality Disorders / Q000453:epidemiology / Q000523:psychology / Q000628:therapy; D011614:Psychotherapy, Brief / Q000379:methods; D013001:Somatoform Disorders / Q000453:epidemiology / Q000523:psychology / Q000628:therapy*; D019966:Substance-Related Disorders / Q000453:epidemiology / Q000517:prevention & control / Q000523:psychology